Plumeria Therapeutics, Inc.
PrivateLast Round
Grant
Oct 30, 2025
Total Funding Raised
$3.97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Plumeria Therapeutics, Inc. is a clinical-stage biotechnology company developing non-opioid pain treatments and companion diagnostics for chronic pain conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plumeria Therapeutics, Inc. Comparables
Compare Plumeria Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaremed AG | 79% | |
| Latigo Biotherapeutics | 79% | |
| EicOsis Human Health, Inc. | 78% | |
Plumeria Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 30, 2025 | ||||
| Grant | Oct 30, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| Grant | Aug 9, 2022 | ||||
| Grant | Jan 20, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Secured $3M in grant funding.
- Oct 30, 2025
Secured $40K in grant funding.
Plumeria Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Plumeria Therapeutics, Inc.'s valuation, stock price, and market status.